carnitine has been researched along with Chronic Hepatitis C in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Serum samples from patients with chronic hepatitis C were subjected to metabolomics analysis to clarify the pretreatment characteristics of their metabolites and also changes in specific metabolites resulting from antiviral therapy with pegylated interferon plus ribavirin (PegIFN/RBV)." | 9.17 | Dynamics of serum metabolites in patients with chronic hepatitis C receiving pegylated interferon plus ribavirin: a metabolomics analysis. ( Igarashi, K; Katsumi, T; Nishise, Y; Okumoto, K; Saito, K; Saito, T; Sato, C; Shao, L; Soga, T; Sugimoto, M; Tomita, K; Tomita, M; Ueno, Y; Watanabe, H, 2013) |
| "In this study, we aimed at determining the contributory role of plasma levels of leptin and carnitine on fatigue in chronic hepatitis C and IBS." | 7.77 | Plasma carnitine is associated with fatigue in chronic hepatitis C but not in the irritable bowel syndrome. ( Anty, R; Bekri, S; Cherikh, F; Dainese, R; DeGalleani, L; Gelsi, E; Marjoux, S; Piche, T; Tran, A, 2011) |
| "Serum samples from patients with chronic hepatitis C were subjected to metabolomics analysis to clarify the pretreatment characteristics of their metabolites and also changes in specific metabolites resulting from antiviral therapy with pegylated interferon plus ribavirin (PegIFN/RBV)." | 5.17 | Dynamics of serum metabolites in patients with chronic hepatitis C receiving pegylated interferon plus ribavirin: a metabolomics analysis. ( Igarashi, K; Katsumi, T; Nishise, Y; Okumoto, K; Saito, K; Saito, T; Sato, C; Shao, L; Soga, T; Sugimoto, M; Tomita, K; Tomita, M; Ueno, Y; Watanabe, H, 2013) |
| "To evaluate the efficacy of L-carnitine on alleviating anemia, thrombocytopenia and leukopenia, and minimizing dose reductions in patients with chronic hepatitis C virus (HCV) in treatment with Interferon α (IFN-α) plus ribavirin." | 5.15 | L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin. ( Bertino, G; Galvano, F; Giordano, M; Li Volti, G; Malaguarnera, M; Motta, M; Neri, S; Pennisi, M; Vacante, M, 2011) |
| "In this study, we aimed at determining the contributory role of plasma levels of leptin and carnitine on fatigue in chronic hepatitis C and IBS." | 3.77 | Plasma carnitine is associated with fatigue in chronic hepatitis C but not in the irritable bowel syndrome. ( Anty, R; Bekri, S; Cherikh, F; Dainese, R; DeGalleani, L; Gelsi, E; Marjoux, S; Piche, T; Tran, A, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Tokuchi, Y | 1 |
| Suda, G | 1 |
| Kimura, M | 1 |
| Maehara, O | 1 |
| Kitagataya, T | 1 |
| Kubo, A | 1 |
| Yoshida, S | 1 |
| Fu, Q | 1 |
| Yang, Z | 1 |
| Hosoda, S | 1 |
| Ohara, M | 1 |
| Yamada, R | 1 |
| Suzuki, K | 1 |
| Kawagishi, N | 1 |
| Nakai, M | 1 |
| Sho, T | 1 |
| Natsuizaka, M | 1 |
| Morikawa, K | 1 |
| Ogawa, K | 1 |
| Ohnishi, S | 1 |
| Sakamoto, N | 1 |
| Sato, C | 2 |
| Saito, T | 2 |
| Misawa, K | 1 |
| Katsumi, T | 2 |
| Tomita, K | 2 |
| Ishii, R | 1 |
| Haga, H | 1 |
| Okumoto, K | 2 |
| Nishise, Y | 2 |
| Watanabe, H | 2 |
| Ueno, Y | 2 |
| Kawata, S | 2 |
| Sugimoto, M | 1 |
| Igarashi, K | 1 |
| Saito, K | 1 |
| Shao, L | 1 |
| Tomita, M | 1 |
| Soga, T | 1 |
| Nishikawa, H | 1 |
| Osaki, Y | 1 |
| Anty, R | 1 |
| Marjoux, S | 1 |
| Bekri, S | 1 |
| DeGalleani, L | 1 |
| Dainese, R | 1 |
| Gelsi, E | 1 |
| Cherikh, F | 1 |
| Tran, A | 1 |
| Piche, T | 1 |
| Malaguarnera, M | 3 |
| Vacante, M | 2 |
| Giordano, M | 1 |
| Motta, M | 1 |
| Bertino, G | 1 |
| Pennisi, M | 1 |
| Neri, S | 1 |
| Li Volti, G | 1 |
| Galvano, F | 1 |
| Romano, M | 1 |
| Cristaldi, E | 1 |
| Colonna, V | 1 |
| Gargante, MP | 1 |
| Cammalleri, L | 1 |
| Kuratsune, H | 1 |
| Yamaguti, K | 1 |
| Lindh, G | 1 |
| Evengard, B | 1 |
| Takahashi, M | 1 |
| Machii, T | 1 |
| Matsumura, K | 1 |
| Takaishi, J | 1 |
| Långström, B | 1 |
| Kanakura, Y | 1 |
| Kitani, T | 1 |
| Watanabe, Y | 1 |
| Eskandari, GH | 1 |
| Polat, G | 1 |
| Tamer, L | 1 |
| Ersöz, G | 1 |
| Atik, U | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia[NCT05501899] | Early Phase 1 | 20 participants (Anticipated) | Interventional | 2023-03-03 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for carnitine and Chronic Hepatitis C
| Article | Year |
|---|---|
Liver Cirrhosis: Evaluation, Nutritional Status, and Prognosis.
Topics: Carcinoma, Hepatocellular; Carnitine; Electric Impedance; Fibrosis; Hand Strength; Hepatitis C, Chro | 2015 |
3 trials available for carnitine and Chronic Hepatitis C
| Article | Year |
|---|---|
Dynamics of serum metabolites in patients with chronic hepatitis C receiving pegylated interferon plus ribavirin: a metabolomics analysis.
Topics: Adult; Aged; Antiviral Agents; Area Under Curve; Betaine; Carnitine; Chromatography, Liquid; Drug Th | 2013 |
L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin.
Topics: Adult; Antiviral Agents; Carnitine; Dietary Supplements; Drug Therapy, Combination; Female; Hepacivi | 2011 |
L-carnitine treatment reduces steatosis in patients with chronic hepatitis C treated with alpha-interferon and ribavirin.
Topics: Adult; Antiviral Agents; Carnitine; Drug Therapy, Combination; Fatty Liver; Female; Hepatitis C, Chr | 2008 |
5 other studies available for carnitine and Chronic Hepatitis C
| Article | Year |
|---|---|
Possible correlation between increased serum free carnitine levels and increased skeletal muscle mass following HCV eradication by direct acting antivirals.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids, Branched-Chain; Antiviral Agents; Carnitine; Female; He | 2021 |
Impaired mitochondrial β-oxidation in patients with chronic hepatitis C: relation with viral load and insulin resistance.
Topics: Adult; Aged; Carnitine; Fasting; Fatty Acids; Fatty Liver; Female; Hepatitis C, Chronic; Homeostasis | 2013 |
Plasma carnitine is associated with fatigue in chronic hepatitis C but not in the irritable bowel syndrome.
Topics: Adult; Aged; Aged, 80 and over; Body Composition; Carnitine; Case-Control Studies; Electric Impedanc | 2011 |
Low levels of serum acylcarnitine in chronic fatigue syndrome and chronic hepatitis type C, but not seen in other diseases.
Topics: Acute Disease; Animals; Carnitine; Chemical and Drug Induced Liver Injury; Diabetes Mellitus; Fatigu | 1998 |
Serum L-carnitine levels and lipoprotein compositions in chronic viral hepatitis patients.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Carnitine; Child; Choles | 2001 |